STB Lifesaving Technologies completes FAST pre-IND submission
The FAST dressing contains large quantities of the human blood clotting proteins fibrinogen, thrombin and Factor XIII in a dry form, which get instantly activated to form a
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.